TechNavio today launched its report Global Laboratory Analytical Instrument Market 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Advancements in DNA sequencer technology is one of the emerging trends in the Global Laboratory Analytical Instrument market. A DNA sequencer is a laboratory analytical instrument which is used in the Pharmaceutical and Biotechnology sectors to automate the DNA sequencing process. DNA sequencing is performed by several R and D teams across the globe in order to study the biology of plants, animals, and microbes, and to analyze the differences between various diseases. DNA sequencer instruments are changing rapidly owing to the advancements in DNA sequencing technology. For instance, the introduction of nanopore DNA sequencing (a hybrid approach to DNA sequencing which combines both first and second-generation DNA sequencing technology) and the electrical detection approach are some of the major advancements in DNA sequencing technology. Furthermore, a few vendors are using electron microscopy to read the nucleotide bases of a single DNA strand. Thus, increasing advancements in DNA sequencer technology will have a positive impact on the growth of the Global Laboratory Analytical Instrument market during the forecast period.”
According to the report, the growing need to comply with US FDA requirements for the commercialization of new drugs is one of the major drivers in the Global Laboratory Analytical Instrument market. A new drug/medicine needs to be tested and analyzed before it is commercialized. Over the past few years, it has become compulsory that, in order for any new drug/medicine to be approved for commercial sale in the US, a report has to be submitted to the FDA detailing the various analytical procedures involved in the manufacturing process and providing information about the composition, strength, quality, purity, and potency of the drug. These analytical procedures are now part of a standard protocol for all biopharmaceutical companies, and these companies have been investing in devices which are capable of conducting the necessary analysis in an efficient and optimum manner. Hence, the use of laboratory analytical instruments such as mass spectrometers, atomic spectroscopes, and elemental analyzers is growing at a rapid rate in sectors such as Food and Beverages and Pharmaceutical.
Further, the report states that the premium price of laboratory analytical instruments is one of the major challenges in the Global Laboratory Analytical Instrument Market.
The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Agilent Technologies Inc., Bruker Corp., Danaher Corp., HORIBA Ltd., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Waters Corp. The other vendors mentioned in the report are Hitachi High-Technologies Corp., Shimadzu Corp., JASCO Inc., B and W Tek Inc., and Illumina Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-laboratory-analytical-instrument…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio